HENDERA
831152
Fujian Nebula Electronics.,Ltd
300648
HNAC Technology
300490
4
Guangzhou LBP Medicine Science & Technology
688393
5
TFL
873152
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.85%51.72B | 15.13%13.56B | 8.93%13.17B | 9.60%12.87B | 9.71%12.12B | 7.36%46.66B | 7.39%11.78B | 12.14%12.09B | -10.24%11.75B | -13.79%11.05B |
Operating revenue | 10.73%50.32B | 15.14%13.15B | 8.84%12.82B | 9.40%12.51B | 9.55%11.83B | 7.66%45.44B | 8.01%11.42B | 12.30%11.78B | -10.52%11.44B | -13.83%10.8B |
Cost of revenue | 2.85%12.83B | 9.99%3.32B | 3.75%3.23B | -5.06%3.17B | 3.51%3.1B | 7.68%12.47B | -0.62%3.02B | 8.46%3.12B | -10.90%3.34B | -22.43%2.99B |
Gross profit | 13.77%38.9B | 16.91%10.23B | 10.73%9.94B | 15.42%9.7B | 12.02%9.02B | 7.24%34.19B | 10.46%8.75B | 13.48%8.98B | -9.97%8.4B | -10.07%8.06B |
Operating expense | -0.28%24.35B | 8.62%6.7B | -12.51%6.31B | 1.59%5.69B | 3.92%5.65B | 2.03%24.42B | 0.03%6.17B | 18.58%7.21B | -21.25%5.6B | -10.94%5.44B |
Selling and administrative expenses | 0.39%12.57B | 1.66%3.5B | 1.39%3.13B | 0.00%3.09B | -1.76%2.84B | 2.66%12.52B | 8.20%3.44B | 5.28%3.09B | -13.68%3.09B | -17.68%2.89B |
Research and development costs | -11.86%10.02B | 10.71%2.84B | -39.06%2.39B | 2.73%2.37B | -5.98%2.42B | 23.98%11.37B | 15.84%2.57B | 54.41%3.93B | -7.77%2.3B | 10.99%2.58B |
Other operating expenses | 232.02%1.76B | 124.22%361M | 298.48%785M | 12.94%227M | 1,492.86%390M | -79.32%531M | -79.12%161M | -67.44%197M | -80.43%201M | -110.22%-28M |
Operating profit | 48.88%14.54B | 36.72%3.53B | 105.85%3.63B | 43.00%4.01B | 28.84%3.37B | 22.94%9.77B | 47.12%2.58B | -3.50%1.76B | 25.99%2.81B | -8.20%2.62B |
Net non-operating interest income expense | -45.11%-608M | 6.67%16M | -14.98%-238M | -30.53%-171M | -123.96%-215M | 27.00%-419M | 1,400.00%15M | 11.54%-207M | 29.57%-131M | 46.96%-96M |
Non-operating interest income | -9.41%568M | ---- | ---- | ---- | ---- | 66.31%627M | ---- | ---- | ---- | ---- |
Non-operating interest expense | 17.66%1.01B | 26.73%275M | 18.92%264M | 13.89%246M | 10.50%221M | 6.88%855M | 4.83%217M | 7.77%222M | 6.93%216M | -0.50%200M |
Total other finance cost | -10.99%170M | -29.87%277M | -73.33%-26M | 11.76%-75M | 94.23%-6M | 26.49%191M | 133.73%395M | -153.57%-15M | -431.25%-85M | -420.00%-104M |
Other net income (expense) | -30.40%-296M | -18.64%-261M | -33.33%-4M | 0.00%-2M | -1,350.00%-29M | -16.41%-227M | -17.65%-220M | 40.00%-3M | -2M | 0.00%-2M |
Gain on sale of security | -20.56%-258M | ---- | ---- | ---- | ---- | -16.30%-214M | ---- | ---- | ---- | ---- |
Earnings from equity interest | -192.31%-38M | 50.00%-3M | -33.33%-4M | 0.00%-2M | -1,350.00%-29M | -18.18%-13M | -100.00%-6M | 40.00%-3M | ---2M | 0.00%-2M |
Income before tax | 49.51%13.64B | 38.20%3.29B | 118.11%3.39B | 43.64%3.84B | 24.17%3.13B | 27.11%9.12B | 51.50%2.38B | -2.21%1.55B | 30.95%2.67B | -5.58%2.52B |
Income tax | 208.71%1.7B | 278.16%465M | 412.82%200M | 47.64%595M | 19.19%441M | -51.15%551M | -202.76%-261M | -84.82%39M | 16.14%403M | -17.78%370M |
Net income | -19.62%11.94B | -66.75%2.82B | 80.66%3.19B | 40.09%3.25B | 17.18%2.69B | 113.57%14.85B | 478.44%8.48B | 11.94%1.76B | 36.70%2.32B | 3.38%2.29B |
Net income continuous Operations | 39.28%11.94B | 6.90%2.82B | 110.51%3.19B | 42.93%3.25B | 25.02%2.69B | 41.71%8.57B | 100.61%2.64B | 13.76%1.51B | 33.98%2.27B | -3.11%2.15B |
Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | 593.38%6.28B | 3,768.87%5.84B | 2.04%250M | --46M | --144M |
Minority interest income | -150.00%-2M | 2M | -300.00%-4M | 0 | 0 | 4M | 0 | 0.00%2M | 0.00%1M | 133.33%1M |
Net income attributable to the parent company | -19.59%11.94B | -66.77%2.82B | 81.09%3.19B | 40.16%3.25B | 17.23%2.69B | 113.52%14.85B | 478.44%8.48B | 11.95%1.76B | 36.72%2.32B | 3.20%2.29B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -19.59%11.94B | -66.77%2.82B | 81.09%3.19B | 40.16%3.25B | 17.23%2.69B | 113.52%14.85B | 478.44%8.48B | 11.95%1.76B | 36.72%2.32B | 3.20%2.29B |
Basic earnings per share | -17.20%5.92 | -65.37%1.42 | 85.88%1.58 | 44.14%1.6 | 20.18%1.31 | 124.14%7.15 | 494.20%4.1 | 16.44%0.85 | 44.16%1.11 | 9.00%1.09 |
Diluted earnings per share | -17.32%5.87 | -65.27%1.41 | 84.71%1.57 | 43.24%1.59 | 21.30%1.31 | 123.97%7.1 | 497.06%4.06 | 18.06%0.85 | 44.16%1.11 | 9.09%1.08 |
Dividend per share | 6.88%3.7395 | 0 | 0 | 0 | 6.88%3.7395 | 5.22%3.4987 | 0 | 0 | 0 | 5.22%3.4987 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |